<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Calcium pangamate (CP) in patients with the cerebrasthenic syndrome of atherosclerotic genesis facilitates a decrease in the cholesterol index of atherogenicity due to increased levels of serum <z:chebi fb="6" ids="39025">high-density lipoproteins</z:chebi> (HDLP) </plain></SENT>
<SENT sid="1" pm="."><plain>One of the factors contributing to an increase in HDLP levels in the patients' blood serum under the impact of CP is the stimulation of the <z:chebi fb="0" ids="16247">phospholipid</z:chebi> incorporation into HDLP </plain></SENT>
</text></document>